Ethics & Informed Consent: Mixed-Methods Study Design (Mexico)
A detailed academic review of the ethical submission protocol, informed consent prerequisites, and reporting standards for conducting a Mixed-Methods Study Design within the regulatory framework of Mexico.
1. Ethical Principles & Legislative Framework
In research involving human participants, securing ethical clearance is a critical first step. For a Mixed-Methods Study Design being conducted in Mexico, study designs must align with the primary regulatory legislation: General Health Law on Health Research (Reglamento de la Ley General de Salud). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.
National Ethics Board Clearance Pathway
In Mexico, human subjects studies must be approved by a CEI registered with CONBIOETICA. Data processing must conform to the LFPDPPP, especially regarding sensitive health details.
Administrative review and formal approval are managed by a local or regional Comité de Ética en Investigación (CEI). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.
2. Study Design Elements & Reporting Integrity
For a Mixed-Methods Study Design, the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.
Study Classification: Minimal to Moderate Risk
This design integrates numeric survey responses with qualitative feedback. Ethical protocols must describe how databases are bridged securely while protecting identity.
To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: GRAMMS framework.
Special Directive: Observational Study Protocols
As an observational or non-interventional design, the ethics board primarily focuses on data privacy, secure pseudonymisation, and informed consent. If you are conducting retrospective database research, you may apply for a waiver of consent, provided participant risk is minimised.
3. Informed Consent & Information Sheet Guidelines
A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:
Design-Specific Consent Focus Areas
Consent covering both survey and interview phases, audio recording permission, and release for using anonymous quotations.
- Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
- Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
- Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under Federal Law on Protection of Personal Information (LFPDPPP).
- Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
- Ethics Board Contact Information: Provide the contact details of the reviewing Comité de Ética en Investigación (CEI) so participants can reach out if they have questions or concerns.
Research Ethics, Clinical Trials & Institutional Governance
The data capture guidelines match the Declaration of Helsinki ethical principles to protect individual identifiers from disclosure. The protocol must outline safe pathways, particularly if any minor deception in psychological research is used in questionnaires. The consenting procedure must follow the ethical principles of informed consent, ensuring participants can opt out anytime. While observational work rarely requires a clinical trial registration, a signed clinical trial agreement contract is required for health networks. Submitting a verified data sharing agreement is necessary to secure final research ethics approval from the Comité de Ética en Investigación (CEI). All records and signed consent sheets must reside on secure local servers in Mexico to protect patient privacy and comply with national guidelines.
4. Regulatory Checklist Table
To streamline your ethical review submission, use the structured alignment checklist below:
| Requirement | Comité de Ética en Investigación (CEI) Standard | GRAMMS framework Standard |
|---|---|---|
| Consent Form | Signed and dated prior to study activity. Focus: Consent covering both survey and interview phases. | Fully documented recruitment and consent paths. |
| Risk Management | Comprehensive risk mitigation plan. Secure linking keys between numeric survey data and interview transcripts stored on separate servers. | Adverse events reporting strategy. |
| Data Retention | Compliance with local data protection rules (Federal Law on Protection of Personal Information (LFPDPPP)). | Provision of open-data options where possible. |
5. Academic & Research Infrastructure Matrix (Mexico)
The following authenticated registry lists top scientific organizations, clinical laboratories, and research hospitals in Mexico mapped via the Research Organization Registry (ROR) standards-compliance framework.
| Organization Name | Sector Type | Registry Identification |
|---|---|---|
| Clinstile (Mexico) | company | ROR ID |
| Novartis (Mexico) | company | ROR IDWikidata/Wiki |
| Wikimedia México | nonprofit | ROR IDWikidata/Wiki |
| Industrias Peñoles | company | ROR IDWikidata/Wiki |
| Secretariat of Energy | funder | ROR IDWikidata/Wiki |
| Cemex (Mexico) | company | ROR IDWikidata/Wiki |
| Sanofi (Mexico) | company | ROR IDWikidata/Wiki |
| Alpek (Mexico) | company | ROR IDWikidata/Wiki |
| Orbia (Mexico) | company | ROR IDWikidata/Wiki |
| Bayer (Mexico) | company | ROR IDWikidata/Wiki |
| Oxfam México | nonprofit | ROR IDWikidata/Wiki |
| Facultad Latinoamericana de Ciencias México | education | ROR IDWikidata/Wiki |
| MSD (Mexico) | company | ROR IDWikidata/Wiki |
| Pemex (Mexico) | company | ROR IDWikidata/Wiki |
| Ministry of Sciences, Humanities, Technology and Innovation | funder | ROR IDWikidata/Wiki |
6. Frequently Asked Questions
How long does the review process normally take?
Review timelines depend on the volume of applications and whether your proposal qualifies for expedited review. On average, a standard review by an ethics board in Mexico takes between 4 to 8 weeks.
Can we use digital signatures for informed consent?
Yes, digital consent forms are increasingly accepted, provided the platform used is secure, authenticates the identity of the signer, and complies with local regulations such as the eIDAS or ESIGN Act, depending on country-specific rules.
Regulatory Context
Verified Funding Bodies
Funder registries and DOI configurations verified for compliance in Mexico via Crossref.
- Health Sciences Center, University of New MexicoID: 100017215 | Location: United States
- Comisión Nacional de Acuacultura y Pesca, Gobierno de MéxicoID: 501100017494 | Location: Mexico
- New Mexico FoundationID: 100021142 | Location: United States
- Eastern New Mexico UniversityID: 100023744 | Location: United States
- New Mexico Children's FoundationID: 100029170 | Location: United States
- New Mexico Geological SocietyID: 100012226 | Location: United States
- New Mexico ArtsID: 100022540 | Location: United States
- New Mexico Water Resources Research Institute, New Mexico State UniversityID: 100013659 | Location: United States
- New Mexico Society of Certified Public AccountantsID: 100030030 | Location: United States
- Historical Society of New MexicoID: 100014992 | Location: United States
Pre-Submission Warning
Do not recruit participants or initiate study procedures before receiving official written approval from your reviewing board. Ethical approvals cannot be granted retrospectively under General Health Law on Health Research (Reglamento de la Ley General de Salud).







